Randomized Multicenter Study of 5 vs 6 Weekly Fraction of RT in the Treatment of SCC of the Head and Neck

Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck

Completed

Looking for future studies?

Key information

Conditions

Carcinoma, Squamous Cell Carcinoma Neoplasms Neoplasms by Histologic Type Neoplasms, Glandular and Epithelial Neoplasms, Squamous Cell

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

KFSH&RC

Riyadh, 1211, Saudi Arabia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with SCC of the head and neck

Treatment and study plan

5 vs 6 weekly fraction of RT

Radiation

Chemotherapy

Primary outcomes

safety

Time frame: 5 years

Sponsors and collaborators

Lead sponsor

King Faisal Specialist Hospital & Research Center

Other

Registry information

Important dates

Study start: 2007
Primary completion: 2015
Study completion: 2015
First posted: Sep 26, 2007
Registry last updated: Mar 1, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed